Sommerer K - Search Results

1

In vitro and in vivo dose delivery characteristics of large porous particles for inhalation.

Dunbar C, Scheuch G, Sommerer K, DeLong M, Verma A, Batycky R. Dunbar C, et al. Among authors: sommerer k. Int J Pharm. 2002 Oct 1;245(1-2):179-89. doi: 10.1016/s0378-5173(02)00349-6. Int J Pharm. 2002. PMID: 12270254 Clinical Trial.

2

Dose delivery characteristics of the AIR pulmonary delivery system over a range of inspiratory flow rates.

DeLong M, Wright J, Dawson M, Meyer T, Sommerer K, Dunbar C. DeLong M, et al. Among authors: sommerer k. J Aerosol Med. 2005 Winter;18(4):452-9. doi: 10.1089/jam.2005.18.452. J Aerosol Med. 2005. PMID: 16379620 Clinical Trial.

3

Targeting delivery of aerosols to different lung regions.

Bennett WD, Brown JS, Zeman KL, Hu SC, Scheuch G, Sommerer K. Bennett WD, et al. Among authors: sommerer k. J Aerosol Med. 2002 Summer;15(2):179-88. doi: 10.1089/089426802320282301. J Aerosol Med. 2002. PMID: 12184868 Review.

4

Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery.

Möller W, Felten K, Sommerer K, Scheuch G, Meyer G, Meyer P, Häussinger K, Kreyling WG. Möller W, et al. Among authors: sommerer k. Am J Respir Crit Care Med. 2008 Feb 15;177(4):426-32. doi: 10.1164/rccm.200602-301OC. Epub 2007 Oct 11. Am J Respir Crit Care Med. 2008. PMID: 17932382

5

Regional Lung Deposition: In Vivo Data.

Häussermann S, Sommerer K, Scheuch G. Häussermann S, et al. Among authors: sommerer k. J Aerosol Med Pulm Drug Deliv. 2020 Dec;33(6):291-299. doi: 10.1089/jamp.2020.29032.sh. Epub 2020 Oct 6. J Aerosol Med Pulm Drug Deliv. 2020. PMID: 33021414

6

The physical and biological doses of methacholine are different for Mefar MB3 and Jaeger APS sidestream nebulizers.

Praml G, Scharrer E, de la Motte D, Nowak D, Scheuch G, Sommerer K, Radon K. Praml G, et al. Among authors: sommerer k. Chest. 2005 Nov;128(5):3585-9. doi: 10.1378/chest.128.5.3585. Chest. 2005. PMID: 16304317

7

Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD.

Meyer T, Reitmeir P, Brand P, Herpich C, Sommerer K, Schulze A, Scheuch G, Newman S. Meyer T, et al. Among authors: sommerer k. Respir Med. 2011 Jun;105(6):900-6. doi: 10.1016/j.rmed.2011.02.007. Epub 2011 Mar 11. Respir Med. 2011. PMID: 21397483 Free article. Clinical Trial.

8

In vitro comparison of two delivery devices for administering formoterol: Foradil P and formoterol ratiopharm single-dose capsule inhaler.

Criée CP, Meyer T, Petro W, Sommerer K, Zeising P. Criée CP, et al. Among authors: sommerer k. J Aerosol Med. 2006 Winter;19(4):466-72. doi: 10.1089/jam.2006.19.466. J Aerosol Med. 2006. PMID: 17196075

9

Insulin lung deposition and clearance following Technosphere® insulin inhalation powder administration.

Cassidy JP, Amin N, Marino M, Gotfried M, Meyer T, Sommerer K, Baughman RA. Cassidy JP, et al. Among authors: sommerer k. Pharm Res. 2011 Sep;28(9):2157-64. doi: 10.1007/s11095-011-0443-4. Epub 2011 Apr 14. Pharm Res. 2011. PMID: 21491144 Clinical Trial.

10

Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.

Häussermann S, Winnips C, Edelman J, Kappeler D, Herpich C, Ehlich H, Zanker D, Kietzig C, Sommerer K. Häussermann S, et al. Among authors: sommerer k. J Aerosol Med Pulm Drug Deliv. 2016 Jun;29(3):242-50. doi: 10.1089/jamp.2014.1173. Epub 2015 Dec 15. J Aerosol Med Pulm Drug Deliv. 2016. PMID: 26669827 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page